- Investing Ideas
- Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
13
Mid-Large Cap Stocks
13 companies
Novartis
Market Cap: CHF 220.2b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 123.42
7D
3.1%
1Y
29.3%
Roche Holding
Market Cap: CHF 254.1b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP
CHF 325.20
7D
0.4%
1Y
24.1%
Tecan Group
Market Cap: CHF 1.9b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 150.00
7D
1.4%
1Y
-7.3%
Bachem Holding
Market Cap: CHF 5.0b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 67.70
7D
3.1%
1Y
15.3%
Sandoz Group
Market Cap: CHF 30.0b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 70.50
7D
5.5%
1Y
66.7%
Cosmo
Market Cap: CHF 1.1b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
COPN
CHF 67.80
7D
-2.6%
1Y
18.5%
SKAN Group
Market Cap: CHF 1.1b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 48.95
7D
0.4%
1Y
-31.4%
Galderma Group
Market Cap: CHF 40.7b
Operates as a dermatology company worldwide.
GALD
CHF 175.30
7D
2.4%
1Y
57.5%
Lonza Group
Market Cap: CHF 35.0b
Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 515.20
7D
4.2%
1Y
-9.6%
Dottikon ES Holding
Market Cap: CHF 4.0b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries.
DESN
CHF 278.00
7D
-6.2%
1Y
-3.6%
Idorsia
Market Cap: CHF 1.5b
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 5.94
7D
31.7%
1Y
214.4%
Siegfried Holding
Market Cap: CHF 3.0b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 68.55
7D
2.5%
1Y
-26.9%
PolyPeptide Group
Market Cap: CHF 1.3b
Operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally.
PPGN
CHF 39.55
7D
11.3%
1Y
95.8%